mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |